Navigation Links
Mylan Vice Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Opening Bell
Date:2/19/2009

PITTSBURGH, Feb. 19 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Vice Chairman and CEO Robert J. Coury will preside over the NASDAQ Stock Market opening on Friday, Feb. 20 from 9:15 to 9:30 a.m. ET. Coury will ring the opening bell to celebrate the company's switch from The New York Stock Exchange (NYSE) to NASDAQ.

Mylan's common stock began trading on NASDAQ Dec. 29, 2008. The company is listed on the NASDAQ Global Select Market, and its common stock continues to trade under the "MYL" ticker symbol. Mylan's mandatory convertible preferred stock and 1.25% convertible notes also moved to NASDAQ with the ticker symbols "MYLNP" and "MYLNG," respectively.

Feed Information - The Opening Bell is available from 9:20 to 9:35 a.m. on Galaxy 19 C/15, downlink frequency 4000 vertical. The feed can also be found on Ascent fiber 1623. Technical questions should be directed to Jolene Libretto at 646-441-5220.

Radio Feed - An audio transmission of the Opening Bell is also available from 9:20 to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.

Webcast - A live webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm.

Photos - To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Mylan

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Schedules Fourth Quarter Financial Results Conference Call and Live Webcast
2. Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
3. Mylan Declares Quarterly Preferred Stock Dividend
4. Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
5. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
6. U.S. Patent and Trademark Office Issues Mylans Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution
7. Mylan to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. Mylans Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
9. Mylan Announces Move to NASDAQ Stock Market
10. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
11. Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... , ... For over twenty-four years, Doctors on Liens has published a directory of ... quality medical care. When the company started in 1997, the directory was a single ... and the now ten-page directory features a vast array of medical specialists stretching ...
(Date:12/2/2016)... Portland, Maine (PRWEB) , ... December 02, 2016 , ... ... support group for caregivers of those affected by autism spectrum disorder (ASD) and other ... and Easter Seals Maine, will give parents and other caregivers the opportunity to share ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... Wilmington, Delaware (PRWEB) , ... December 02, 2016 ... ... has released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite ... from sample entry through labeling, storing, shipping and disposal. The new version is ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... Rijuven ... stress and overall health, day and night. No other wearable health technology on the ... We wanted to give poeple more meaningful insights about their health than the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... OLD LYME, Conn. , Dec. 1, 2016 /PRNewswire/ ... consulting, has announced the honor of being selected as ... that include: Simpson Healthcare Executives Website at the PLATINUM ... Directed Conversations Training Module at the GOLD Level, and ... At Simpson Healthcare Executives, we are ...
(Date:12/2/2016)... , Dec. 2, 2016 Allergan plc (NYSE: ... additional information on its previously announced Accelerated Share Repurchase (ASR) ... ... As previously announced, the Company entered into ... which the Company will repurchase $10 billion of its ordinary ...
(Date:11/30/2016)... -- Research and Markets has announced the addition of ... report to their offering. ... Detachable coil embolization is a minimally ... detachable coil embolization treatment of cerebral aneurysms is less invasive and requires ... in the wall of an artery in the brain. This area bulges ...
Breaking Medicine Technology: